MAQUET Cardiovascular’s continued expansion and ramp-up of its wholly-owned manufacturing facility will hire up to 350 new employees while maintaining jobs for 1,100 statewide residents as it seeks to ramp up its wholly-owned manufacturing activities that were previously conducted primarily in Puerto Rico. The company hopes to expand its New Jersey work force in the future but, like many medical device companies, is concerned about potential new taxes that would inhibit growth in the medical technology sector. The company has already invested nearly $40 million to develop its new headquarters and manufacturing areas. The 282,000 square foot site will include manufacturing and house a Surgical Academy and Showroom, complete with full-scale operating room environments for training and education. Construction is also slated to start soon on an auditorium that will seat 180 people with multimedia capabilities, including interpreting and production booths.

“MAQUET Cardiovascular has deep ties to the state of New Jersey, and it is with great honor and pride that we dedicate our new facility today,” said Christian Keller, President and CEO, MAQUET Cardiovascular. “From our new U.S. headquarters and through the dedication of our employees around the globe, we plan to exceed in our commitment to deliver technology and products that improve the clinical and economic outcomes for high acuity cardiac patients.”

“MAQUET would like to thank the New Jersey Economic Development Authority for its support of our growth efforts,” said William Friedberg, President of MAQUET Cardiovascular’s Vascular Interventions business unit. “The cooperative nature of the state government, favorable economic incentives, and the skilled workforce of the surrounding areas made Wayne, New Jersey, the perfect community in which to develop our world-class facilities and headquarters.”